OSIC: A Global Force Transforming ILD Research
OSIC is a global, 501(c)(3) nonprofit cooperative uniting academia, industry and patient advocacy groups with a singular mission: to revolutionize research in interstitial lung diseases (ILDs) and rare fibrosing lung conditions. Central to this mission is the OSIC Cloud Data Repository — the world’s largest, most diverse ILD database dedicated to advancing knowledge and patient care worldwide.
Breaking Barriers Through Global Collaboration
Rare and complex diseases like ILDs demand more than cutting-edge technology — they require relentless momentum, shared expertise, and cross-border cooperation. ILDs affect people across every continent and culture. Only by harnessing diverse data and uniting stakeholders globally can we overcome the limitations of narrow datasets and develop solutions that reflect real-world diversity and complexity.
Our Mission
Be passionate in our quest to make radical progress on behalf of people living with ILDs, their families and caregivers.
OSIC fosters collaboration and innovation between computational scientists, and industry competitors from around the world in ways that hadn’t yet been considered to advance digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy. The partners work in pre-competitive areas for mutual benefit and, most importantly, the benefit of patients.
Our first-of-its-kind, curated ILD database is rich with diverse, global data that is organized, accurate and accessible for research
OSIC has built the world’s largest and most diverse global data repository for ILDs, with more than 20,000 anonymized HRCT scans and accompanying clinical data committed from multiple institutions and databases to date. Through the use of digital imaging and machine learning, OSIC members are utilizing this first‑of‑its‑kind, curated database to help clinicians speed diagnosis, aid prognosis, and treat patients living with these diseases more efficiently and effectively.
COMMITTED DATA TO DATE
20,789 anonymized scans with accompanying clinical data
Committed goal surpassed: 15,000 anonymized scans
Driven by Leading Subject-matter Experts
The OSIC Core Science Leadership Team has partnered with a diverse team of experts to tackle the challenges of IPF, ILDs, and the technology needed to make progress.
Dr. Kevin Brown
OSIC Pulmonology Lead
National Jewish Health
Prof. David Barber
OSIC Computational Science Lead
University College London
Dr. Jonathan Chung
OSIC Radiology Lead (US)
University of California, San Diego
Prof. Joseph Jacob
OSIC Radiology Lead (EU)
University College London Hospitals
Institutional Partners
These organizations have made multi-year commitments of funding and/or pledged to contribute with imaging and clinical data or with other means to OSIC to ensure that it is positioned for success.